Summit Global Investments’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Other funds holding USNA
NCM
Summit Global Investments's USNA Position: Q4 2025 in Review
Summit Global Investments sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 7,871 shares — an estimated $217K sold.
Summit Global Investments first reported a position in USNA in Q3 2020 and held it in 13 quarters. The position peaked at $1.97M in Q2 2021. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.
- Summit Global Investments reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
- Summit Global Investments sold 7,871 Usana Health Sciences shares in Q4 2025, an estimated $217K.
- Summit Global Investments first reported a position in Usana Health Sciences in Q3 2020 and held it in 13 quarters.
- Summit Global Investments's Usana Health Sciences position peaked at $1.97M in Q2 2021.
- 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.
Based on Summit Global Investments's 13F filing for Q4 2025, filed 18 Feb 2026.